Generate a tailored SOP for Dr. Daniel Weinberger. Improve your application with a focused, well-structured draft.
Daniel Weinberger is the Director and CEO of the Lieber Institute for Brain Development and a Professor at Johns Hopkins University. He leads a multi-disciplinary translational neurobiology research institute focused on understanding the cellular and neural systems mechanisms associated with genetic risk for schizophrenia and related developmental cognitive disorders. His landmark developments have contributed to a significant shift in the understanding and approach to these disorders, emphasizing the neurodevelopmental origins and the characterization of their phenomenology. Over his career, he has directed teams studying the genetic regulation of the transcriptome of the normal human brain across the lifespan, using extensive clinical datasets that include over a thousand affected and unaffected families. His research involves analyzing DNA, lymphoblast, and fibroblast cell lines, as well as conducting detailed cognitive assessments and neuroimaging assays. Dr. Weinberger is actively exploring the implications of genetic variations on cognition and temperament, testing multiple case-control datasets to develop polygenic risk models pertinent to cognitive and neuroimaging phenotypes. He is also investigating the effects of genetic susceptibility on antipsychotic drug responses.
Department of Pathology - PhD in Pathobiology. GRE is not required.